Patents by Inventor Scott D. Feighner

Scott D. Feighner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7179886
    Abstract: The motilin receptor has been isolated and cloned, and nucleic acid sequences are given. Two spice variants have been identified. Also, assays for motilin receptor ligands are given. The identification of the cloned motilin receptor may be used to screen and identify compounds which bind to the receptor for use in a variety of gastric conditions, including gastric motility disorders.
    Type: Grant
    Filed: June 8, 1999
    Date of Patent: February 20, 2007
    Assignee: Merck & Co., Inc.
    Inventors: Scott D. Feighner, Arthur A. Patchett, Carina Tan, Karen Kulju McKee, Douglas MacNeil, Andrew D. Howard, Sheng-Shung Pong, Roy G. Smith
  • Publication number: 20030166144
    Abstract: Human, swine and rat growth hormone secretagogue receptors have been isolated, cloned and sequenced. Growth hormone secretagogue receptors are new members of the G-protein family of receptors. The growth hormone secretagogue receptors may be used to screen and identify compounds which bind to the growth hormone secretagogue receptor. Such compounds may be used in the treatment of conditions which occur when there is a shortage of growth hormone, such as observed in growth hormone deficient children, elderly patients with musculoskeletal impairment and recovering from hip fracture and osteoporosis.
    Type: Application
    Filed: November 25, 2002
    Publication date: September 4, 2003
    Applicant: Merck & Co., Inc.
    Inventors: Joseph P. Arena, Doris F. Cully, Scott D. Feighner, Andrew D. Howard, Paul A. Liberator, James M. Schaeffer, Leonardus H. T. Van Der Ploeg
  • Patent number: 6531314
    Abstract: Human, swine and rat growth hormone secretagogue receptors have been isolated, cloned and sequenced. Growth hormone secretagogue receptors are new members of the G-protein family of receptors. The growth hormone secretagogue receptors may be used to screen and identify compounds which bind to the growth hormone secretagogue receptor. Such compounds may be used in the treatment of conditions which occur when there is a shortage of growth hormone, such as observed in growth hormone deficient children, elderly patients with musculoskeletal impairment and recovering from hip fracture and osteoporosis.
    Type: Grant
    Filed: June 3, 1998
    Date of Patent: March 11, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Joseph P. Arena, Doris F. Cully, Scott D. Feighner, Andrew D. Howard, Paul A. Liberator, James M. Schaeffer, Leonardus H. T. Van Der Ploeg
  • Patent number: 6242199
    Abstract: An assay for the detection of growth hormone secretagogue receptors and growth hormone secretagogue related receptors is described. As these receptors are a member of the G protein coupled receptors, a subunit of the G protein must be present in order for expression to be detected. A similar assay is described where the presence of growth hormone secretagogues are detected.
    Type: Grant
    Filed: June 3, 1998
    Date of Patent: June 5, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Lee-Yuh Pai, Scott D. Feighner, Andrew D. Howard, Sheng-Shung Pong, Leonardus H. T. Van Der Ploeg
  • Patent number: 5563256
    Abstract: Unique species-specific Eimeria tenella DNA probes comprising divergent DNA sequences are disclosed. The probes are complementary to a small subunit ribosomal RNA gene of Eimeria tenella.
    Type: Grant
    Filed: May 12, 1992
    Date of Patent: October 8, 1996
    Assignee: Merck & Co., Inc.
    Inventors: Prasanta R. Chakraborty, Michael Dashkevicz, Alex Elbrecht, Scott D. Feighner, Paul A. Liberator, Helen Profous-Juchelka
  • Patent number: 5449768
    Abstract: Unique species-specific Eimeria praecox DNA probes comprising divergent DNA sequences are disclosed. The probes are complementary to a small subunit ribosomal RNA gene of Eimeria praecox.
    Type: Grant
    Filed: May 12, 1992
    Date of Patent: September 12, 1995
    Assignee: Merck and Co., Inc.
    Inventors: Prasanta R. Chakraborty, Michael Dashkevicz, Alex Elbrecht, Scott D. Feighner, Paul A. Liberator, Helen Profous-Juchelka
  • Patent number: 5359050
    Abstract: Unique species-specific Eimeria mitis DNA probes comprising divergent DNA sequences are disclosed. The probes ere complementary to a small subunit ribosomal RNA gene of Eimeria mitis.
    Type: Grant
    Filed: May 12, 1992
    Date of Patent: October 25, 1994
    Assignee: Merck and Co., Inc.
    Inventors: Prasanta R. Chakraborty, Alex Elbrecht, Michael Dashkevicz, Scott D. Feighner, Paul A. Liberator, Helen Profous-Juchelka
  • Patent number: 5350763
    Abstract: Unguinol is a well-known metabolite of the fungi Aspergillus unguis and Aspergillus nidulans. Unguinol has been found to be an active growth permittant and promotant in animals, in particular, monogastric animals such as chickens. In addition, the fermentation broth also produced the additional known unguinol derivatives of folipastatin and 2-chloro unguinol as well as the novel 4-methyl derivative. All of these compounds are active animal growth permittants. Compositions containing such unguinol derivatives for use as growth permittants and promotants are also disclosed.
    Type: Grant
    Filed: June 11, 1993
    Date of Patent: September 27, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Scott D. Feighner, Gino M. Salituro, Jack L. Smith, Nancy N. Tsou
  • Patent number: 5298613
    Abstract: Unique species-specific Eimeria acervulina DNA probes comprising divergent DNA sequences are disclosed. The probes are complementary to a small subunit ribosomal RNA gene of Eimeria acervulina.
    Type: Grant
    Filed: May 12, 1992
    Date of Patent: March 29, 1994
    Assignee: Merck and Co., Inc.
    Inventors: Prasanta R. Chakraborty, Alex Elbrecht, Michael Dashkevicz, Scott D. Feighner, Paul A. Liberator, Helen Profous-Juchelka
  • Patent number: 5288845
    Abstract: Unique species-specific Eimeria necatrix DNA probes comprising divergent DNA sequences are disclosed. The probes are complementary to a small subunit ribosomal RNA gene of Eimeria necatrix.
    Type: Grant
    Filed: May 12, 1992
    Date of Patent: February 22, 1994
    Assignee: Merck and Co., Inc.
    Inventors: Prasanta R. Chakraborty, Michael Dashkevicz, Alex Elbrecht, Scott D. Feighner, Paul A. Liberator, Helen Profous-Juchelka
  • Patent number: 5278298
    Abstract: Unique species-specific Eimeria brunetti DNA probes comprising divergent DNA sequences are disclosed. The probes are complementary to a small subunit ribosomal RNA gene of Eimeria brunetti.
    Type: Grant
    Filed: May 12, 1992
    Date of Patent: January 11, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Prasanta R. Chakraborty, Alex Elbrecht, Michael Dashkevicz, Scott D. Feighner, Paul A. Liberator, Helen Profous-Juchelka
  • Patent number: 5266689
    Abstract: Unique species-specific Eimeria maxima DNA probes comprising divergent DNA sequences are disclosed. The probes are complementary to a small subunit ribosomal RNA gene of Eimeria maxima.
    Type: Grant
    Filed: May 12, 1992
    Date of Patent: November 30, 1993
    Assignee: Merck and Co., Inc.
    Inventors: Prasanta R. Chakraborty, Michael Dashkevicz, Alex Elbrecht, Scott D. Feighner, Paul A. Liberator, Helen Profous-Juchelka